We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Thomson Reuters
TRI
$42.8B
| $312K | ﹤0.01% |
+7,062
| New | +$331K |
|
|
CTB
777
DELISTED
Cooper Tire & Rubber Co.
CTB
| $312K | ﹤0.01% |
9,225
-153,782
| -94% | -$5.91M |
|
778
Acadia Healthcare
ACHC
$2.76B
| $311K | ﹤0.01% |
+3,975
| New | +$286K |
|
|
ARG
779
DELISTED
Airgas Inc
ARG
| $311K | ﹤0.01% |
2,940
-2,114
| -42% | -$221K |
|
|
CAB
780
DELISTED
Cabela's Inc
CAB
| $309K | ﹤0.01% |
+6,180
| New | +$327K |
|
781
TechnipFMC
FTI
$28.1B
| $307K | ﹤0.01% |
9,960
-555,520
| -98% | -$17.1M |
|
|
AWAY
782
DELISTED
HOMEAWAY INC COM
AWAY
| $306K | ﹤0.01% |
+9,831
| New | +$293K |
|
783
Nelnet
NNI
$4.88B
| $304K | ﹤0.01% |
7,012
-5,638
| -45% | -$248K |
|
784
Enovis
ENOV
$1.68B
| $303K | ﹤0.01% |
3,818
-5,078
| -57% | -$430K |
|
785
Itron
ITRI
$4.36B
| $301K | ﹤0.01% |
8,737
+1,636
| +23% | +$59.4K |
|
786
Tetra Tech
TTEK
$8.49B
| $301K | ﹤0.01% |
+58,785
| New | +$301K |
|
787
Willis Towers Watson
WTW
$31.2B
| $300K | ﹤0.01% |
2,416
+566
| +31% | +$72.1K |
|
|
BMR
788
DELISTED
BIOMED REALTY TRUST INC
BMR
| $300K | ﹤0.01% |
+15,535
| New | +$322K |
|
|
IPG
789
DELISTED
Interpublic Group of Companies
IPG
| $299K | ﹤0.01% |
15,501
-4,032
| -21% | -$83.7K |
|
|
PPS
790
DELISTED
Post Properties
PPS
| $299K | ﹤0.01% |
+5,491
| New | +$309K |
|
791
AXIS Capital
AXS
$7.68B
| $298K | ﹤0.01% |
+5,586
| New | +$301K |
|
792
Cathay General Bancorp
CATY
$4.22B
| $298K | ﹤0.01% |
+9,184
| New | +$278K |
|
793
CDW
CDW
$18.9B
| $298K | ﹤0.01% |
+8,700
| New | +$325K |
|
|
CYS
794
DELISTED
CYS Investments Inc.
CYS
| $298K | ﹤0.01% |
38,582
+10,386
| +37% | +$91.4K |
|
795
Cal-Maine
CALM
$4.12B
| $297K | ﹤0.01% |
5,694
-9,920
| -64% | -$488K |
|
|
QVCGA
796
DELISTED
QVC Group Inc Series A
QVCGA
| $297K | ﹤0.01% |
+221
| New | +$307K |
|
|
SGEN
797
DELISTED
Seagen Inc. Common Stock
SGEN
| $297K | ﹤0.01% |
6,130
-6,844
| -53% | -$282K |
|
798
Hyatt Hotels
H
$16.4B
| $296K | ﹤0.01% |
5,223
-5,102
| -49% | -$297K |
|
799
Upbound Group
UPBD
$1.13B
| $296K | ﹤0.01% |
+10,448
| New | +$314K |
|
800
Clorox
CLX
$11.6B
| $295K | ﹤0.01% |
+2,837
| New | +$306K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.